{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:10:04Z","timestamp":1793304604891,"version":"4.5.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s10620-012-2334-x","type":"journal-article","created":{"date-parts":[[2012,8,18]],"date-time":"2012-08-18T07:07:31Z","timestamp":1345273651000},"page":"23-32","source":"Crossref","is-referenced-by-count":99,"title":["Probiotic\/Synbiotic Therapy for Treating Critically Ill Patients from a Gut Microbiota Perspective"],"prefix":"10.1007","volume":"58","author":[{"given":"Kentaro","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Asahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Nomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Morotomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Tasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asako","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Kuwagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Shimazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,19]]},"reference":[{"key":"2334_CR1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/gut.45.2.223","volume":"45","author":"J MacFie","year":"1999","unstructured":"MacFie J, O\u2019Boyle C, Mitchell CJ, Buckley PM, Johnstone D, Sudworth P. Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut. 1999;45:223\u2013228.","journal-title":"Gut"},{"key":"2334_CR2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/shk.0b013e31805569df","volume":"28","author":"JA Clark","year":"2007","unstructured":"Clark JA, Coopersmith CM. Intestinal crosstalk: a new paradigm for understanding the gut as the \u201cmotor\u201d of critical illness. Shock. 2007;28:384\u2013393.","journal-title":"Shock"},{"key":"2334_CR3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.clnu.2006.01.021","volume":"25","author":"KG Kreymann","year":"2006","unstructured":"Kreymann KG, Berger MM, Deutz NE, et al. ESPEN guidelines on enteral nutrition: intensive care. Clin Nutr. 2006;25:210\u2013223.","journal-title":"Clin Nutr"},{"key":"2334_CR4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","volume":"36","author":"RP Dellinger","year":"2008","unstructured":"Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296\u2013327.","journal-title":"Crit Care Med"},{"key":"2334_CR5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/gut.2007.143172","volume":"57","author":"J Meddings","year":"2008","unstructured":"Meddings J. The significance of the gut barrier in disease. Gut. 2008;57:438\u2013440.","journal-title":"Gut"},{"key":"2334_CR6","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0140-6736(03)12489-0","volume":"361","author":"F Guarner","year":"2003","unstructured":"Guarner F, Malagelada JR. Gut flora in health and disease. Lancet. 2003;361:512\u2013519.","journal-title":"Lancet"},{"key":"2334_CR7","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/sj.embor.7400731","volume":"7","author":"AM O\u2019Hara","year":"2006","unstructured":"O\u2019Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 2006;7:688\u2013693.","journal-title":"EMBO Rep"},{"key":"2334_CR8","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/infdis\/157.5.1032","volume":"157","author":"EK Steffen","year":"1988","unstructured":"Steffen EK, Berg RD, Deitch EA. Comparison of translocation rates of various indigenous bacteria from the gastrointestinal tract to the mesenteric lymph node. J Infect Dis. 1988;157:1032\u20131038.","journal-title":"J Infect Dis"},{"key":"2334_CR9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1128\/AAC.38.3.409","volume":"38","author":"EJ Vollaard","year":"1994","unstructured":"Vollaard EJ, Clasener HA. Colonization resistance. Antimicrob Agents Chemother. 1994;38:409\u2013414.","journal-title":"Antimicrob Agents Chemother"},{"key":"2334_CR10","doi-asserted-by":"crossref","first-page":"II118","DOI":"10.1007\/s00394-004-1205-4","volume":"43","author":"JH Cummings","year":"2004","unstructured":"Cummings JH, Antoine JM, Azpiroz F, et al. PASSCLAIM\u2014gut health and immunity. Eur J Nutr. 2004;43:II118\u2013II173.","journal-title":"Eur J Nutr"},{"key":"2334_CR11","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nri2653","volume":"9","author":"JR Turner","year":"2009","unstructured":"Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009;9:799\u2013809.","journal-title":"Nat Rev Immunol"},{"key":"2334_CR12","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.1124234","volume":"312","author":"SR Gill","year":"2006","unstructured":"Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312:1355\u20131359.","journal-title":"Science"},{"key":"2334_CR13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nri2515","volume":"9","author":"JL Round","year":"2009","unstructured":"Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9:313\u2013323.","journal-title":"Nat Rev Immunol"},{"key":"2334_CR14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","volume":"139","author":"II Ivanov","year":"2009","unstructured":"Ivanov II, Atarashi K, Manel N, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139:485\u2013498.","journal-title":"Cell"},{"key":"2334_CR15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1198469","volume":"331","author":"K Atarashi","year":"2011","unstructured":"Atarashi K, Tanoue T, Shima T, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011;331:337\u2013341.","journal-title":"Science"},{"key":"2334_CR16","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1111\/j.1365-2222.2005.02379.x","volume":"35","author":"MC Noverr","year":"2005","unstructured":"Noverr MC, Huffnagle GB. The \u2018microflora hypothesis\u2019 of allergic diseases. Clin Exp Allergy. 2005;35:1511\u20131520.","journal-title":"Clin Exp Allergy"},{"key":"2334_CR17","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1126\/science.1195568","volume":"330","author":"YK Lee","year":"2010","unstructured":"Lee YK, Mazmanian SK. Has the microbiota played a critical role in the evolution of the adaptive immune system? Science. 2010;330:1768\u20131773.","journal-title":"Science"},{"key":"2334_CR18","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nri1499","volume":"4","author":"PJ Sansonetti","year":"2004","unstructured":"Sansonetti PJ. War and peace at mucosal surfaces. Nat Rev Immunol. 2004;4:953\u2013964.","journal-title":"Nat Rev Immunol"},{"key":"2334_CR19","first-page":"171","volume-title":"Physiological and Clinical Aspects of Short-Chain Fatty Acids","author":"C R\u00e9m\u00e9sy","year":"1995","unstructured":"R\u00e9m\u00e9sy C, Demign\u00e9 C, Morand C. Metabolism of short chain fatty acids in the liver. In: Cummings JH, Rombeau JL, Sakata T, eds. Physiological and Clinical Aspects of Short-Chain Fatty Acids. Cambridge: Cambridge University Press; 1995:171\u2013190."},{"key":"2334_CR20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1079\/PNS2002207","volume":"62","author":"S Macfarlane","year":"2003","unstructured":"Macfarlane S, Macfarlane GT. Regulation of short-chain fatty acid production. Proc Nutr Soc. 2003;62:67\u201372.","journal-title":"Proc Nutr Soc"},{"key":"2334_CR21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1574-6968.2002.tb11467.x","volume":"217","author":"SE Pryde","year":"2002","unstructured":"Pryde SE, Duncan SH, Hold GL, Stewart CS, Flint HJ. The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett. 2002;217:133\u2013139.","journal-title":"FEMS Microbiol Lett"},{"key":"2334_CR22","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/nature08530","volume":"461","author":"KM Maslowski","year":"2009","unstructured":"Maslowski KM, Vieira AT, Ng A, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009;461:1282\u20131286.","journal-title":"Nature"},{"key":"2334_CR23","first-page":"183","volume":"46","author":"J Fallingborg","year":"1999","unstructured":"Fallingborg J. Intraluminal pH of the human gastrointestinal tract. Dan Med Bull. 1999;46:183\u2013196.","journal-title":"Dan Med Bull"},{"key":"2334_CR24","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/00003246-199206000-00025","volume":"20","author":"American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference","year":"1992","unstructured":"American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864\u2013874.","journal-title":"Crit Care Med"},{"key":"2334_CR25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1067\/msy.2002.116408","volume":"131","author":"EA Deitch","year":"2002","unstructured":"Deitch EA. Bacterial translocation or lymphatic drainage of toxic products from the gut: what is important in human beings? Surgery. 2002;131:241\u2013244.","journal-title":"Surgery"},{"key":"2334_CR26","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1378\/chest.09-2267","volume":"136","author":"RC Bone","year":"2009","unstructured":"Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine. 1992. Chest. 2009;136:e28.","journal-title":"Chest"},{"key":"2334_CR27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/01.ta.0000197374.99755.fe","volume":"60","author":"K Shimizu","year":"2006","unstructured":"Shimizu K, Ogura H, Goto M, et al. Altered gut flora and environment in patients with severe SIRS. J Trauma. 2006;60:126\u2013133.","journal-title":"J Trauma"},{"key":"2334_CR28","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s10620-010-1418-8","volume":"56","author":"K Shimizu","year":"2011","unstructured":"Shimizu K, Ogura H, Hamasaki T, et al. Altered gut flora are associated with septic complications and death in critically ill patients with systemic inflammatory response syndrome. Dig Dis Sci. 2011;56:1171\u20131177.","journal-title":"Dig Dis Sci"},{"key":"2334_CR29","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10620-008-0460-2","volume":"54","author":"K Shimizu","year":"2009","unstructured":"Shimizu K, Ogura H, Goto M, et al. Synbiotics decrease the incidence of septic complications in patients with severe SIRS: a preliminary report. Dig Dis Sci. 2009;54:1071\u20131078.","journal-title":"Dig Dis Sci"},{"key":"2334_CR30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00423-004-0536-1","volume":"390","author":"H Kanazawa","year":"2005","unstructured":"Kanazawa H, Nagino M, Kamiya S, et al. Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg. 2005;390:104\u2013113.","journal-title":"Langenbecks Arch Surg"},{"key":"2334_CR31","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.3201\/eid1411.080589","volume":"14","author":"S Nakamura","year":"2008","unstructured":"Nakamura S, Maeda N, Miron IM, et al. Metagenomic diagnosis of bacterial infections. Emerg Infect Dis. 2008;14:1784\u20131786.","journal-title":"Emerg Infect Dis"},{"key":"2334_CR32","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1172\/JCI43918","volume":"120","author":"C Ubeda","year":"2010","unstructured":"Ubeda C, Taur Y, Jenq RR, et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest. 2010;120:4332\u20134341.","journal-title":"J Clin Invest"},{"key":"2334_CR33","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1007\/s10620-010-1486-9","volume":"56","author":"K Shimizu","year":"2011","unstructured":"Shimizu K, Ogura H, Tomono K, et al. Patterns of gram-stained fecal flora as a quick diagnostic marker in patients with severe SIRS. Dig Dis Sci. 2011;56:1782\u20131788.","journal-title":"Dig Dis Sci"},{"key":"2334_CR34","unstructured":"FAO\/WHO. Report, Joint FAO\/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria; October 1\u20134, 2001."},{"key":"2334_CR35","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1263\/jbb.100.583","volume":"100","author":"K Nomoto","year":"2005","unstructured":"Nomoto K. Prevention of infections by probiotics. J Biosci Bioeng. 2005;100:583\u2013592.","journal-title":"J Biosci Bioeng"},{"key":"2334_CR36","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/jn\/125.6.1401","volume":"125","author":"GR Gibson","year":"1995","unstructured":"Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995;125:1401\u20131412.","journal-title":"J Nutr"},{"key":"2334_CR37","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3177\/jnsv.39.635","volume":"39","author":"M Ito","year":"1993","unstructured":"Ito M, Deguchi Y, Matsumoto K, Kimura M, Onodera N, Yajima T. Influence of galactooligosaccharides on the human fecal microflora. J Nutr Sci Vitaminol (Tokyo). 1993;39:635\u2013640.","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"2334_CR38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrmicro2297","volume":"8","author":"S Lebeer","year":"2010","unstructured":"Lebeer S, Vanderleyden J, De Keersmaecker SC. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol. 2010;8:171\u2013184.","journal-title":"Nat Rev Microbiol"},{"key":"2334_CR39","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1128\/IAI.01563-06","volume":"75","author":"M Schlee","year":"2007","unstructured":"Schlee M, Wehkamp J, Altenhoefer A, Oelschlaeger TA, Stange EF, Fellermann K. Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect Immun. 2007;75:2399\u20132407.","journal-title":"Infect Immun"},{"key":"2334_CR40","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nm.2087","volume":"16","author":"TB Clarke","year":"2010","unstructured":"Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med. 2010;16:228\u2013231.","journal-title":"Nat Med"},{"key":"2334_CR41","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/IAI.72.4.2240-2247.2004","volume":"72","author":"T Asahara","year":"2004","unstructured":"Asahara T, Shimizu K, Nomoto K, Hamabata T, Ozawa A, Takeda Y. Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7. Infect Immun. 2004;72:2240\u20132247.","journal-title":"Infect Immun"},{"key":"2334_CR42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1348-0421.2010.00224.x","volume":"54","author":"E Lkhagvadorj","year":"2010","unstructured":"Lkhagvadorj E, Nagata S, Wada M, et al. Anti-infectious activity of synbiotics in a novel mouse model of methicillin-resistant Staphylococcus aureus infection. Microbiol Immunol. 2010;54:265\u2013275.","journal-title":"Microbiol Immunol"},{"key":"2334_CR43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00007890-200207150-00021","volume":"74","author":"N Rayes","year":"2002","unstructured":"Rayes N, Seehofer D, Hansen S, et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation. 2002;74:123\u2013127.","journal-title":"Transplantation"},{"key":"2334_CR44","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1007\/s00268-005-0653-1","volume":"30","author":"K Kotzampassi","year":"2006","unstructured":"Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A, Kazamias P, Eleftheriadis E. Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically ill trauma patients: early results of a randomized controlled trial. World J Surg. 2006;30:1848\u20131855.","journal-title":"World J Surg"},{"key":"2334_CR45","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/0148607107031002119","volume":"31","author":"A Spindler-Vesel","year":"2007","unstructured":"Spindler-Vesel A, Bengmark S, Vovk I, Cerovic O, Kompan L. Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. JPEN J Parenter Enteral Nutr. 2007;31:119\u2013126.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"2334_CR46","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/TA.0b013e31819d979e","volume":"67","author":"EJ Giamarellos-Bourboulis","year":"2009","unstructured":"Giamarellos-Bourboulis EJ, Bengmark S, Kanellakopoulou K, Kotzampassi K. Pro- and synbiotics to control inflammation and infection in patients with multiple injuries. J Trauma. 2009;67:815\u2013821.","journal-title":"J Trauma"},{"key":"2334_CR47","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s00134-008-1368-1","volume":"35","author":"DJ Knight","year":"2009","unstructured":"Knight DJ, Gardiner D, Banks A, et al. Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial. Intensive Care Med. 2009;35:854\u2013861.","journal-title":"Intensive Care Med"},{"key":"2334_CR48","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1186\/cc6907","volume":"12","author":"C Forestier","year":"2008","unstructured":"Forestier C, Guelon D, Cluytens V, Gillart T, Sirot J, De Champs C. Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients. Crit Care. 2008;12:R69.","journal-title":"Crit Care"},{"key":"2334_CR49","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1164\/rccm.200912-1853OC","volume":"182","author":"LE Morrow","year":"2010","unstructured":"Morrow LE, Kollef MH, Casale TB. Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med. 2010;182:1058\u20131064.","journal-title":"Am J Respir Crit Care Med"},{"key":"2334_CR50","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1046\/j.1365-2168.2002.02189.x","volume":"89","author":"A Ol\u00e1h","year":"2002","unstructured":"Ol\u00e1h A, Bel\u00e1gyi T, Issekutz A, Gamal ME, Bengmark S. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg. 2002;89:1103\u20131107.","journal-title":"Br J Surg"},{"key":"2334_CR51","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(08)60207-X","volume":"371","author":"MG Besselink","year":"2008","unstructured":"Besselink MG, van Santvoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371:651\u2013659.","journal-title":"Lancet"},{"key":"2334_CR52","doi-asserted-by":"crossref","first-page":"c77","DOI":"10.1136\/bmj.c77","volume":"340","author":"T Sheldon","year":"2010","unstructured":"Sheldon T. Dutch probiotics study is criticised for its \u201cdesign, approval, and conduct.\u201d BMJ. 2010;340:c77.","journal-title":"BMJ"},{"key":"2334_CR53","doi-asserted-by":"crossref","unstructured":"Expression of concern\u2014probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;375:875\u2013876.","DOI":"10.1016\/S0140-6736(10)60360-1"},{"key":"2334_CR54","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/MCO.0b013e32834fcea8","volume":"15","author":"LE Morrow","year":"2012","unstructured":"Morrow LE, Gogineni V, Malesker MA. Synbiotics and probiotics in the critically ill after the PROPATRIA trial. Curr Opin Clin Nutr Metab Care. 2012;15:147\u2013150.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2334_CR55","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00259435","volume":"10","author":"CP Stoutenbeek","year":"1984","unstructured":"Stoutenbeek CP, van Saene HK, Miranda DR, Zandstra DF. The effect of selective decontamination of the digestive tract on colonisation and infection rate in multiple trauma patients. Intensive Care Med. 1984;10:185\u2013192.","journal-title":"Intensive Care Med"},{"key":"2334_CR56","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(03)14409-1","volume":"362","author":"E Jonge de","year":"2003","unstructured":"de Jonge E, Schultz MJ, Spanjaard L, et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet. 2003;362:1011\u20131016.","journal-title":"Lancet"},{"key":"2334_CR57","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa0800394","volume":"360","author":"AM Smet de","year":"2009","unstructured":"de Smet AM, Kluytmans JA, Cooper BS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med. 2009;360:20\u201331.","journal-title":"N Engl J Med"},{"key":"2334_CR58","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/01.sla.0000154148.58154.d5","volume":"241","author":"MA Cal de La","year":"2005","unstructured":"de La Cal MA, Cerda E, Garcia-Hierro P, et al. Survival benefit in critically ill burned patients receiving selective decontamination of the digestive tract: a randomized, placebo-controlled, double-blind trial. Ann Surg. 2005;241:424\u2013430.","journal-title":"Ann Surg"},{"key":"2334_CR59","doi-asserted-by":"crossref","unstructured":"Liberati A, D\u2019Amico R, Pifferi S, Torri V, Brazzi L, Parmelli E. Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database Syst Rev. 2009:CD000022.","DOI":"10.1002\/14651858.CD000022.pub3"},{"key":"2334_CR60","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jhin.2006.10.014","volume":"65","author":"L Silvestri","year":"2007","unstructured":"Silvestri L, van Saene HK, Milanese M, Gregori D, Gullo A. Selective decontamination of the digestive tract reduces bacterial bloodstream infection and mortality in critically ill patients. Systematic review of randomized, controlled trials. J Hosp Infect. 2007;65:187\u2013203.","journal-title":"J Hosp Infect"},{"key":"2334_CR61","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1097\/CCM.0b013e3181d9db8c","volume":"38","author":"L Silvestri","year":"2010","unstructured":"Silvestri L, van Saene HK, Zandstra DF, Marshall JC, Gregori D, Gullo A. Impact of selective decontamination of the digestive tract on multiple organ dysfunction syndrome: systematic review of randomized controlled trials. Crit Care Med. 2010;38:1370\u20131376.","journal-title":"Crit Care Med"},{"key":"2334_CR62","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0140-6736(92)92422-C","volume":"340","author":"JM Hammond","year":"1992","unstructured":"Hammond JM, Potgieter PD, Saunders GL, Forder AA. Double-blind study of selective decontamination of the digestive tract in intensive care. Lancet. 1992;340:5\u20139.","journal-title":"Lancet"},{"key":"2334_CR63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00003246-199701000-00014","volume":"25","author":"C Verwaest","year":"1997","unstructured":"Verwaest C, Verhaegen J, Ferdinande P, et al. Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit. Crit Care Med. 1997;25:63\u201371.","journal-title":"Crit Care Med"},{"key":"2334_CR64","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0195-6701(98)90258-4","volume":"39","author":"W Lingnau","year":"1998","unstructured":"Lingnau W, Berger J, Javorsky F, Fille M, Allerberger F, Benzer H. Changing bacterial ecology during a five-year period of selective intestinal decontamination. J Hosp Infect. 1998;39:195\u2013206.","journal-title":"J Hosp Infect"},{"key":"2334_CR65","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1097\/01.CCM.0000079606.16776.C5","volume":"31","author":"M Leone","year":"2003","unstructured":"Leone M, Albanese J, Antonini F, Nguyen-Michel A, Martin C. Long-term (6-year) effect of selective digestive decontamination on antimicrobial resistance in intensive care, multiple-trauma patients. Crit Care Med. 2003;31:2090\u20132095.","journal-title":"Crit Care Med"},{"key":"2334_CR66","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1055\/s-2006-933669","volume":"27","author":"MJ Bonten","year":"2006","unstructured":"Bonten MJ, Krueger WA. Selective decontamination of the digestive tract: cumulating evidence, at last? Semin Respir Crit Care Med. 2006;27:18\u201322.","journal-title":"Semin Respir Crit Care Med"},{"key":"2334_CR67","unstructured":"Shimizu K, Nakagawa Y, Ogura H, et al. A case report of a severe alcoholic hepatitis with prominent increased white blood cells in blood and ascites. Kanzo. 2005;46:682\u2013683 (in Japanese)."},{"key":"2334_CR68","doi-asserted-by":"crossref","unstructured":"Snydman DR. The safety of probiotics. Clin Infect Dis. 2008;46:S104\u2013S111; discussion S144\u2013S151.","DOI":"10.1086\/523331"},{"key":"2334_CR69","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3945\/ajcn.2009.28759","volume":"91","author":"K Whelan","year":"2010","unstructured":"Whelan K, Myers CE. Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials. Am J Clin Nutr. 2010;91:687\u2013703.","journal-title":"Am J Clin Nutr"},{"key":"2334_CR70","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1128\/CDLI.10.1.169-173.2003","volume":"10","author":"T Asahara","year":"2003","unstructured":"Asahara T, Takahashi M, Nomoto K, et al. Assessment of safety of lactobacillus strains based on resistance to host innate defense mechanisms. Clin Diagn Lab Immunol. 2003;10:169\u2013173.","journal-title":"Clin Diagn Lab Immunol"},{"key":"2334_CR71","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00134-006-0452-7","volume":"33","author":"S Fruhwald","year":"2007","unstructured":"Fruhwald S, Holzer P, Metzler H. Intestinal motility disturbances in intensive care patients pathogenesis and clinical impact. Intensive Care Med. 2007;33:36\u201344.","journal-title":"Intensive Care Med"},{"key":"2334_CR72","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1097\/00003246-199908000-00006","volume":"27","author":"JC Montejo","year":"1999","unstructured":"Montejo JC. Enteral nutrition-related gastrointestinal complications in critically ill patients: a multicenter study. The Nutritional and Metabolic Working Group of the Spanish Society of Intensive Care Medicine and Coronary Units. Crit Care Med. 1999;27:1447\u20131453.","journal-title":"Crit Care Med"},{"key":"2334_CR73","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2982.2010.01653.x","volume":"23","author":"K Shimizu","year":"2011","unstructured":"Shimizu K, Ogura H, Asahara T, et al. Gastrointestinal dysmotility is associated with altered gut flora and septic mortality in patients with severe systemic inflammatory response syndrome: a preliminary study. Neurogastroenterol Motil. 2011;23:330\u2013335.","journal-title":"Neurogastroenterol Motil"},{"key":"2334_CR74","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clnu.2007.08.001","volume":"27","author":"MK Herbert","year":"2008","unstructured":"Herbert MK, Holzer P. Standardized concept for the treatment of gastrointestinal dysmotility in critically ill patients\u2014current status and future options. Clin Nutr. 2008;27:25\u201341.","journal-title":"Clin Nutr"},{"key":"2334_CR75","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.amjsurg.2006.01.022","volume":"192","author":"S Endo","year":"2006","unstructured":"Endo S, Nishida T, Nishikawa K, et al. Dai-kenchu-to, a Chinese herbal medicine, improves stasis of patients with total gastrectomy and jejunal pouch interposition. Am J Surg. 2006;192:9\u201313.","journal-title":"Am J Surg"},{"key":"2334_CR76","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-6143.2004.00649.x","volume":"5","author":"N Rayes","year":"2005","unstructured":"Rayes N, Seehofer D, Theruvath T, et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation\u2014a randomized, double-blind trial. Am J Transplant. 2005;5:125\u2013130.","journal-title":"Am J Transplant"},{"key":"2334_CR77","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/01.sla.0000219039.20924.88","volume":"244","author":"G Sugawara","year":"2006","unstructured":"Sugawara G, Nagino M, Nishio H, et al. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg. 2006;244:706\u2013714.","journal-title":"Ann Surg"},{"key":"2334_CR78","first-page":"661","volume":"54","author":"T Nomura","year":"2007","unstructured":"Nomura T, Tsuchiya Y, Nashimoto A, et al. Probiotics reduce infectious complications after pancreaticoduodenectomy. Hepatogastroenterology. 2007;54:661\u2013663.","journal-title":"Hepatogastroenterology"},{"key":"2334_CR79","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.sla.0000259442.78947.19","volume":"246","author":"N Rayes","year":"2007","unstructured":"Rayes N, Seehofer D, Theruvath T, et al. Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: a randomized, double-blind trial. Ann Surg. 2007;246:36\u201341.","journal-title":"Ann Surg"},{"key":"2334_CR80","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.amjsurg.2010.02.013","volume":"201","author":"S Eguchi","year":"2011","unstructured":"Eguchi S, Takatsuki M, Hidaka M, Soyama A, Ichikawa T, Kanematsu T. Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: a prospective randomized study. Am J Surg. 2011;201:498\u2013502.","journal-title":"Am J Surg"},{"key":"2334_CR81","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/0148607110379813","volume":"35","author":"M Usami","year":"2011","unstructured":"Usami M, Miyoshi M, Kanbara Y, et al. Effects of perioperative synbiotic treatment on infectious complications, intestinal integrity, and fecal flora and organic acids in hepatic surgery with or without cirrhosis. JPEN J Parenter Enteral Nutr. 2011;35:317\u2013328.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"2334_CR82","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.clnu.2003.12.002","volume":"23","author":"PK Jain","year":"2004","unstructured":"Jain PK, McNaught CE, Anderson AD, MacFie J, Mitchell CJ. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Clin Nutr. 2004;23:467\u2013475.","journal-title":"Clin Nutr"},{"key":"2334_CR83","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.clnu.2004.08.008","volume":"24","author":"CE McNaught","year":"2005","unstructured":"McNaught CE, Woodcock NP, Anderson AD, MacFie J. A prospective randomised trial of probiotics in critically ill patients. Clin Nutr. 2005;24:211\u2013219.","journal-title":"Clin Nutr"},{"key":"2334_CR84","first-page":"590","volume":"54","author":"A Ol\u00e1h","year":"2007","unstructured":"Ol\u00e1h A, Bel\u00e1gyi T, P\u00f3t\u00f3 L, Romics L Jr, Bengmark S. Synbiotic control of inflammation and infection in severe acute pancreatitis: a prospective, randomized, double blind study. Hepatogastroenterology. 2007;54:590\u2013594.","journal-title":"Hepatogastroenterology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-012-2334-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T17:53:28Z","timestamp":1594576408000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-012-2334-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,19]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["2334"],"URL":"https:\/\/doi.org\/10.1007\/s10620-012-2334-x","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,19]]}}}